Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Perspective Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 127 | 4 | 135 | +12 |
| Shares | 49.1M | 985.8K | 47.3M | −868.0K (−1.8%) |
| Value | $654.9M | $12.6M | $150.7M | −$491.6M (−76.5%) |
4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (36)
Institutions that held Perspective Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (24)
Institutions that held Perspective Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Commodore Capital LP | 3,350,000 | $44.7M |
| Paradigm Biocapital Advisors LP | 919,692 | $12.3M |
| Adage Capital Partners GP, L.L.C. | 750,000 | $10.0M |
| ExodusPoint Capital Management, LP | 581,614 | $7.76M |
| Ally Bridge Group (NY) LLC | 341,739 | $4.56M |
| StemPoint Capital LP | 238,084 | $3.18M |
| Silverarc Capital Management, LLC | 167,986 | $2.24M |
| Sofinnova Investments, Inc. | 120,632 | $1.61M |
| Sandler Capital Management | 102,806 | $1.37M |
| Rafferty Asset Management, LLC | 101,138 | $1.35M |
| Atika Capital Management LLC | 100,000 | $1.34M |
| Osterweis Capital Management Inc | 91,293 | $1.22M |
| AlphaCentric Advisors LLC | 80,000 | $1.07M |
| LMR Partners LLP | 30,000 | $400.5K |
| RIA Advisory Group LLC | 25,620 | $342.0K |
| Sectoral Asset Management Inc | 20,400 | $272.3K |
| Profund Advisors LLC | 20,261 | $270.5K |
| nVerses Capital, LLC | 4,300 | $57.4K |
| Acadian Asset Management LLC | 2,871 | $38.0K |
| Group One Trading, L.P. | 100 | $1.33K |
| Bryn Mawr Trust Co | 83 | $1.11K |
| Rothschild Investment LLC | 55 | $734 |
| Lindbrook Capital, LLC | 31 | $414 |
| International Assets Investment Management, LLC | 1,202 | – |
Not filed for Q4 2024 yet (4)
Institutions that held Perspective Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Ghost Tree Capital, LLC | 750,000 | $10.0M |
| Eagle Asset Management Inc | 181,467 | $2.04M |
| ClariVest Asset Management LLC | 54,199 | $540.4K |
| Planning Capital Management Corp | 115 | $1.54K |